Evaluation of sympathetic innervation in patients with atrial fibrillation by nuclear medicine imaging

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024774

Enrollment

Registered

2021-03-16

Start date

2013-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0 I48.0

Interventions

Group 1: Patients with symptomatic paroxysmal atrial fibrillation will receive a therapy according to current ESC guidelines including antiarrhythmic drug therapy and/or pulmonary vein isolation regar

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: paroxysmal atrial fibrillation

Exclusion criteria

Exclusion criteria: CHD, structural heart disease, persistent, permanent atrial fibrillation

Design outcomes

Primary

Measure	Time frame
rhythm control in follow up	—

Secondary

Measure	Time frame
sympathetic innervation mIBG/SPECT imaging	—

Countries

Germany

Contacts

Public ContactPhilipp S. Lange

Klinik für Kardiologie IIUniversitätsklinikum Münster

philippsebastian.lange@ukmuenster.de0251/83-47820

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026